← brief for 2026-10-06 · Slowing decline

Cardiometabolic medicine in China: Burden, challenges, and strategic priorities

Article No results yet Peer reviewed

Key takeaways

This review looks at how heart, metabolic, and kidney diseases are linked in China. It discusses the challenges of treating these conditions together. It is a background review, so it reports no new trial results.

Who did this work

Rui‐Xiang Zeng (Guangzhou University of Chinese Medicine) · Sha Li (Chinese Academy of Medical Sciences & Peking Union Medical College) · Xiao Wang (Chinese Academy of Medical Sciences & Peking Union Medical College) · Kefei Dou (Chinese Academy of Medical Sciences & Peking Union Medical College) · Jian-Jun Li (Chinese Academy of Medical Sciences & Peking Union Medical College)

Source

Article · OpenAlex, Kidney disease concept sweep (verified C2778653478) · 2026-10-05
https://doi.org/10.1016/j.metop.2026.100505